
- Volume 0 0
RA, Osteoporosis, and Exercise
For patients with rheumatoid arthritis (RA)?particularly older women?the risk of osteoporotic fractures due to low bone mass is double that of patients without RA. According to Dr. Ole Rintek Madsen of Bispebjerg University in Copenhagen and his colleagues, however, a regimen of regular exercise could provide help in preserving bone mass and strength in such patients.
Writing in the April issue of Annals of the Rheumatic Diseases, Dr. Madsen reported on his team?s investigation of the relationship between bone mineral density and associated factors in 67 women who had had RA for an average of 15 years. Most were taking glucocorticoids, which carry a known increased osteoporosis risk.
The strength of the women?s thigh muscles was linked to bone strength using several measures that are independent of age, disease duration, and total steroid dosage over time. Women with lower thigh muscle strength were found to have below-normal thighbone density.
According to Dr. Madsen, this outcome reveals that ?reduced muscle strength is a stronger determinant of bone mass than are other traditional markers of disease severity. The finding emphasizes the importance of exercise programs in the prevention of bone loss and osteoporotic fractures in rheumatoid arthritis.?
Articles in this issue
over 23 years ago
HOT OTC Introductions in 2001over 23 years ago
Making the "White" Choice: OTC Tooth-Whitening Productsover 23 years ago
Norelgestromin/ Ethinyl Estradiol (Ortho Evra)over 23 years ago
Lawyers Have Latitude in Closing Argumentsover 23 years ago
Incomplete Directions Can Lead to Dispensing Errorsover 23 years ago
Pharmacodynamic Drug Interactions with Ziprasidoneover 23 years ago
An Update on Hepatitis Cover 23 years ago
Medication Advice for Travelersover 23 years ago
Allergic Rhinitis: A Focus on Nonprescription Therapyover 23 years ago
Animal Protein May Protect Bone Mineral DensityNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































